RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
7.26
-0.12 (-1.63%)
At close: May 5, 2026, 4:00 PM EDT
7.25
-0.01 (-0.14%)
After-hours: May 5, 2026, 6:36 PM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $299.59 million as of May 5, 2026. Its market cap has decreased by -48.72% in one year.
Market Cap
299.59M
Enterprise Value
83.54M
1-Year Change
-48.72%
Ranking
Category
Stock Price
$7.26
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $299.59M, a decrease of -29.40%. That is a compound annual growth rate of -7.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 304.55M | -28.92% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | 424.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OrthoPediatrics | 405.31M |
| Delcath Systems | 379.00M |
| Viemed Healthcare | 364.82M |
| Standard BioTools | 364.72M |
| CapsoVision | 352.44M |
| ClearPoint Neuro | 335.24M |
| TriSalus Life Sciences | 273.29M |
| Profound Medical | 251.41M |